酰胺质子转移成像可能预测高级别胶质瘤的生存和IDH突变状态
纳入71例病理诊断的高级别胶质瘤患者,术前行APT成像MRI。高APT信号是不良OS和PFS的独立预测因子,并较临床因素和分子标志物提供显著增量预后价值。IDH野生型较高APT信号显著相关(p=0.001),MGMT甲基化状态无差异(p=0.208)。APT成像可能预测IDH突变状态。
要点
- 高APT信号与高级别胶质瘤较差的总生存和无进展生存独立相关。
- APT信号在IDH野生型中显著高于IDH突变型(p=0.001)。
- APT信号较临床因素和分子标志物提供显著增量预后价值。
核心结论
- 高APT信号是高级别胶质瘤不良预后的显著预测因子,APT数据较临床预后因素和分子标志物有显著增量预后价值,并可能预测IDH突变状态。
研究设计与样本
- 纳入71例病理诊断的高级别胶质瘤(WHO III/IV级)患者,术前接受包含APT成像的MRI检查。
诊断标准与关键数值
- 单因素分析:高APT信号预测不良OS的HR=3.21(95%CI=1.62-6.34),预测不良PFS的HR=2.22(95%CI=1.33-3.72)。
- 多因素分析(仅纳入临床因素):高APT信号预测不良OS的HR=2.89、预测不良PFS的HR=2.13。
- 多因素分析(临床因素联合分子标志物):高APT信号预测不良OS的HR=2.85、预测不良PFS的HR=2.00。
- IDH野生型与高APT信号显著相关(p=0.001),MGMT甲基化状态与APT信号无差异(p=0.208)。
- 使用整合AUC(iAUC)比较模型性能,APT信号的增量预后价值对OS和PFS均显著。
临床应用与阅片要点
- 作者认为APT成像可能对术前筛查和治疗指导有价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the utility of amide proton transfer (APT) imaging as an imaging biomarker to predict prognosis and molecular marker status in high-grade glioma (HGG, WHO grade III/IV).
METHODS: We included 71 patients with pathologically diagnosed HGG who underwent preoperative MRI with APT imaging. Overall survival (OS) and progression-free survival (PFS) according to APT signal, clinical factors, MGMT methylation status, and IDH mutation status were analyzed. Multivariate Cox regression models with and without APT signal data were constructed. Model performance was compared using the integrated AUC (iAUC). Associations between APT signals and molecular markers were assessed using the Mann-Whitney test.
RESULTS: High APT signal was a significant predictor for poor OS (HR = 3.21, 95% CI = 1.62-6.34) and PFS (HR = 2.22, 95% CI = 1.33-3.72) on univariate analysis. On multivariate analysis, high APT signals were an independent predictor of poor OS and PFS when clinical factors alone (OS: HR = 2.89; PFS: HR = 2.13), or in combination with molecular markers (OS: HR = 2.85; PFS: HR = 2.00), were included as covariates. The incremental prognostic value of APT signals was significant for OS and PFS. IDH-wild type was significantly associated with high APT signals (p = 0.001) when compared to IDH-mutant; however, there was no difference based on MGMT methylation status (p = 0.208).
CONCLUSION: High APT signal was a significant predictor of poor prognosis in HGG. APT data showed significant incremental prognostic value over clinical prognostic factors and molecular markers and may also predict IDH mutation status.
KEY POINTS: • Amide proton transfer (APT) imaging is a promising prognostic marker of high-grade glioma. • APT signals were significantly higher in IDH-wild type compared to IDH-mutant high-grade glioma. • APT imaging may be valuable for preoperative screening and treatment guidance.
引用
- Joo B, Han K, Ahn SS, et al. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma. Eur Radiol. 2019. PMID: 31175415. doi:10.1007/s00330-019-06203-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。